MRVINasdaqPharmaceutical PreparationsFiscal year ends December 31
MARAVAI LIFESCIENCES HOLDINGS, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$6.99+0.20 (+2.95%)
Close on Oct 19, 2026
- Market cap
- $1.03B
- P/E (TTM)
- –
- Dividend yield
- –
MARAVAI LIFESCIENCES HOLDINGS, INC. revenue by segment
By business segment
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TriLink | – | – | – | $127.09M | $155.58M | $179.08M | $196.35M | $213.27M | $210.66M | $209.33M | $224.77M | $355.23M | – | – |
| Cygnus | – | – | – | $65.35M | $64.25M | $62.78M | $62.84M | $63.50M | $63.95M | $64.77M | $64.18M | $64.28M | – | – |
By product or service
By region
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | $119.44M | $118.80M | $112.38M | $111.80M | $121.39M | $122.99M | $127.09M | $131.93M | $131.83M | $133.92M | $141.06M | $174.99M | 57.2% | -1.6% |
| Europe, the Middle East and Africa | $48.05M | $45.99M | $30.92M | $30.92M | $34.32M | $39.57M | $42.06M | $50.53M | $46.79M | $50.30M | $49.92M | $130.78M | 23.0% | +40.0% |
| Asia Pacific | $39.95M | $38.79M | $41.47M | $48.96M | $63.54M | $78.80M | $89.38M | $93.60M | $95.30M | $89.21M | $97.44M | $113.10M | 19.1% | -37.1% |
| Latin and Central America | $1.34M | $1.15M | $971.00K | $756.00K | $585.00K | $501.00K | $662.00K | $707.00K | $687.00K | $681.00K | $527.00K | $649.00K | 0.6% | +128.2% |
From the segment and revenue-disaggregation notes of Maravai Lifesciences's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.